FDA Adverse Event Injury Summary report: N

UNKNOWN_PUMP

MDR report key: 3773847 · Received April 25, 2014

Report

Report Number
3007566237-2014-01159
Event Type
Injury
Date Received
April 25, 2014
Report Date
April 11, 2014
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID NEU_UNKNOWN_CATH, LOT# UNKNOWN, PRODUCT TYPE: CATHETER. (B)(4).

Description of Event or Problem · 1

GHOSH, D., MAINALI, G., KHERA, J., LUCIANO, M. COMPLICATIONS OF INTRATHECAL BACLOFEN PUMPS IN CHILDREN: EXPERIENCE FROM A TERTIARY CARE CENTER. PEDIATRIC NEUROSURGERY. 2014. SUMMARY: INTRATHECAL BACLOFEN (ITB) THERAPY IS USEFUL IN TREATING SPASTICITY AND DYSTONIA BUT IT HAS MANY COMPLICATIONS, MORE SO IN CHILDREN. THE MAIN AIM OF THE STUDY WAS TO LOOK AT THE COMPLICATIONS OF ITB PUMPS IN CHILDREN WITH THE GOAL OF FUTURE PREVENTION. CHARTS OF ALL PATIENTS= 21 YEARS WITH AN ITB PUMP, IMPLANTED BY A SINGLE PEDIATRIC NEUROSURGEON, AT A SINGLE CENTER, BETWEEN 1996 AND 2011 WERE REVIEWED RETROSPECTIVELY. DATA REGARDING AN ITB TEST TRIAL WERE ALSO RECORDED. DURING 1996¿2011, 119 CHILDREN (MEAN AGE 13.2 YEARS) UNDERWENT ITB PUMP PLACEMENT; 84% HAD SPASTIC QUADRIPLEGIC CEREBRAL PALSY. THE GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM LEVEL WAS =4 FOR MOST. THE PUMP WAS REMOVED IN 5 (4.2%) PATIENTS DUE TO INEFFICACY. THE MEAN FOLLOW-UP WAS 38 MONTHS. MECHANICAL COMPLICATIONS REQUIRING PUMP AND/OR CATHETER REVISION OCCURRED IN 19.3% AND INFECTIONS IN AN ADDITIONAL 21.8%. SEVEN PATIENTS (6%) HAD MENINGITIS. NO COMPLICATION WAS NOTED AFTER 72 MONTHS OF INITIAL PUMP INSERTION, EVEN AFTER PUMP REINSERTION. THERE IS A NEED FOR BETTER INFECTION CONTROL AS WELL AS BETTER PUMP, CATHETER AND SURGICAL TECHNOLOGY TO LOWER THE COMPLICATIONS OF ITB PUMPS IN CHILDREN. REPORTED EVENT: AN (B)(6) WITH TRAUMATIC BRAIN INJURY, SUBARACHNOID HEMORRHAGE, AND A VENTRICULOPERITONEAL SHUNT DEVELOPED MENINGITIS WITHOUT INFECTION AT THE INCISION SITE. THE PUMP HAD BEEN PLACED IN 2001 WITH THE CATHETER TIP AT T10. THE MENINGITIS DEVELOPED 10 DAYS AFTER IMPLANT. (B)(6) WAS CULTURED AND IV ANTIBIOTICS WERE ADMINISTERED. THE PATIENT HAD NO SEQUELAE. THIS PATIENT WAS PREVIOUSLY REPORTED WITH LIMITED INFORMATION FROM AN OLDER RELATED ARTICLE UNDER MANUFACTURER REPORT # 2182207-2008-06650 (2008). THE SOURCE OF THE PREVIOUS ARTICLE IS LISTED BELOW. PLEASE DISREGARD THAT REPORT AND CONSIDER THIS THE ACTIVE REPORT. ANY ADDITIONAL INFORMATION RECEIVED WILL BE FILED UNDER THIS REPORT. PREVIOUS ARTICLE: KHERA J, GHOSH D, LUCIANO M. A STUDY OF INTRATHECAL BACLOFEN PUMPS IN CHILDREN: EXPERIENCE FROM A TERTIARY CARE CENTER. NEUROLOGY. 2008;70(11, SUPPL.1):A131. TO DETERMINE INDICATIONS, UTILITY, AND COMPLICATIONS OF INTRATHECAL BACLOFEN (ITB) PUMP THERAPY IN CHILDREN. SINGLE CENTER, RETROSPECTIVE REVIEW AFTER IRB APPROVAL. INCLUSION CRITERIA: PATIENTS <(><<)> 21 YEARS WITH ITB PUMP PLACED BETWEEN 1996-2006. MASTER FILE: 0700597953.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
252595 UNKNOWN_PUMP PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION UNKNOWN_PUMP

Patients

Seq Age Sex Outcome Treatment
1 00018 YR Required Intervention